<ѻýҕl>Wearable Tech Shows Promise for Predicting IBD Flaresѻýҕl> App measured heart rate variability metrics in patients with Crohn's, ulcerative colitis Jan 21, 2023
<ѻýҕl>Contrary to Guidelines, 5-ASA Often Prescribed in Pediatric Crohn's Diseaseѻýҕl> Use at diagnosis associated with delays in starting biologics Jan 20, 2023
<ѻýҕl>IBD Risk Higher After Antibioticsѻýҕl> Dose-response relationship found, especially for older individuals Jan 09, 2023
<ѻýҕl>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One!ѻýҕl> Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<ѻýҕl>Small Study Shows Most Crohn's Patients With Anal Cancer Survivedѻýҕl> 15 of 24 were alive and cancer free at 5.5 years of follow-up Dec 09, 2022
<ѻýҕl>Antibiotic Exposure Before Age 2 Tied to Increased Risk of Pediatric IBDѻýҕl> Even exposure during the last trimester of pregnancy increases this risk, researchers say Dec 08, 2022
<ѻýҕl>Do Kidney Transplant Medications Supplant IBD Drugs?ѻýҕl> Study shows many patients no longer need drugs to help keep gut disease in check Dec 08, 2022
<ѻýҕl>Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patientsѻýҕl> Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
<ѻýҕl>COVID-19 Booster Vaccine Appears Safe for IBD Patientsѻýҕl> Third shot reactions mirror earlier primary doses, study showed Dec 07, 2022
<ѻýҕl>Infliximab Maintenance Home Infusion Appears Safeѻýҕl> Few serious adverse events occurred in patient-friendly settings Dec 07, 2022
<ѻýҕl>Xeljanz Cancer Risks Detailedѻýҕl> New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<ѻýҕl>Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitisѻýҕl> Post-hoc analysis showed symptom relief as early as day 1 with the JAK inhibitor Dec 02, 2022
<ѻýҕl>Nearly 1 in 7 Adults Experience Bloating on Any Given Weekѻýҕl> Some individuals report feeling uncomfortable discussing it with their doctors Nov 17, 2022
<ѻýҕl>Pandemic's Impact on Liver Disease in the Spotlight at Liver Meetingѻýҕl> A roundup of news from the AASLD annual meeting Nov 04, 2022
<ѻýҕl>Continuing Ozanimod Prevented More Relapses in Ulcerative Colitisѻýҕl> Disease control also maintained with temporary withdrawal, at least initially Oct 28, 2022
<ѻýҕl>Upadacitinib Maintenance Triples Clinical Remissions in Crohn's Diseaseѻýҕl> U-ENDURE trial also hit co-primary endpoint for endoscopic response Oct 27, 2022
<ѻýҕl>Two More IBD Drugs Cleared for Safety During Pregnancyѻýҕl> Ustekinumab, vedolizumab not linked to greater risk of complications Oct 26, 2022
<ѻýҕl>Guselkumab-Golimumab Combo Shows Promise for Ulcerative Colitisѻýҕl> More clinical remissions, endoscopic improvements, early trial finds Oct 26, 2022
<ѻýҕl>Higher Upadacitinib Dose May Be Better for UC Maintenanceѻýҕl> Post-hoc analysis suggested less severe disease and longer remission over 1 year Oct 24, 2022
<ѻýҕl>Do Crohn's Patients Do Better With Early Surgery?ѻýҕl> Danish study finds fewer reoperations, though higher risk for hospitalization Oct 20, 2022
<ѻýҕl>Eating More Unprocessed Foods Tied to Lower Risk of Crohn's Diseaseѻýҕl> No association seen for ulcerative colitis, however Oct 14, 2022
<ѻýҕl>Some Environmental Pollutants Linked to IBSѻýҕl> PM2.5, airborne toxic releases associated with zip code-level IBS incidence in California Oct 04, 2022
<ѻýҕl>Higher Risk for Treatment Failure With Vedolizumab in Older IBD Patientsѻýҕl> Particularly for Crohn's disease, according to comparative effectiveness study Sep 30, 2022
<ѻýҕl>Have We Been Overcautious With TNF Inhibitors in Pregnancy?ѻýҕl> Study of IBD patients finds no basis for common practice Sep 26, 2022
<ѻýҕl>Noninvasive Gastric Mapping; Best Foods for the Gut? Lab Score for Crohn'sѻýҕl> News and commentary from the world of gastroenterology and hepatology Sep 22, 2022
<ѻýҕl>IV Iron Replacements Go Head-to-Head for IBD-Related Anemiaѻýҕl> Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose Sep 16, 2022
<ѻýҕl>Ryan Reynolds' Colonoscopy; NASH Drug Passes Phase II Test; New Drug Target in IBD?ѻýҕl> News and commentary from the world of gastroenterology and hepatology Sep 14, 2022
<ѻýҕl>New Drug for Gastric Ulcers; Linzess for Kids' Constipation; IBD Meds Safe in Uteroѻýҕl> News and commentary from the world of gastroenterology and hepatology Sep 08, 2022
<ѻýҕl>First-in-Class Drug Brings Relief in Ulcerative Colitisѻýҕl> Multiple doses of obefazimod bested placebo in randomized trial Sep 07, 2022
<ѻýҕl>Complete Endoscopic Healing in IBD Linked to Lower Relapse Riskѻýҕl> Though about a third of these patients still relapsed after cessation of TNF inhibitors Sep 02, 2022
<ѻýҕl>MMR Vaccination Tied to Lower IBD Risk for Kidsѻýҕl> Parents hesitant to vaccinate should be reassured, study authors say Aug 24, 2022
<ѻýҕl>Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximabѻýҕl> French study showed low relapse rates across all intravenous dose regimens, except for one Aug 19, 2022
<ѻýҕl>C-Section Babies Face Higher Crohn's Disease Risk Later in Lifeѻýҕl> Underlying mechanism could be the gut microbiome, researcher hypothesizes Aug 17, 2022
<ѻýҕl>What's the Best New Drug for Luminal Crohn's Disease?ѻýҕl> Meta-analysis ranks infliximab and others, but experts urge results are not ready for prime time Aug 04, 2022
<ѻýҕl>More Bad Safety News for Xeljanzѻýҕl> Yet another risk confirmed in postmarketing study Aug 04, 2022
<ѻýҕl>Medical Trauma in Patients With IBDѻýҕl> Hospitalizations, flares, and pain cited as sources of post-traumatic stress Aug 01, 2022
<ѻýҕl>Improving Small Bowel Capsule Endoscopy Visualizationѻýҕl> Meta-analysis shows 15% improvement in adequate small bowel cleansing with purgative preparations Jul 26, 2022
<ѻýҕl>TNF Inhibitors, Thiopurines May Help Reduce Recurrent Acute Arterial Eventsѻýҕl> IBD patients with previous events saw lower risk of recurrence, according to French study Jul 19, 2022
<ѻýҕl>Genotype Tied to Azathioprine Discontinuation for Toxicityѻýҕl> Nearly threefold risk seen with a genotype most common among Black patients Jun 20, 2022
<ѻýҕl>FDA OKs Risankizumab for Crohn's Diseaseѻýҕl> Approval marks the third indication for the IL-23 inhibitor in adults Jun 17, 2022